Additionally, this nanomedicine combination can increase PDT sensitivity, and inhibit glycolysis by downregulating HIF-1α, which also lights up a new possibility for PDT-based gene therapy for tumor treatment. The gene discussed is HIF1A; the disease is neoplasm.